Dyslipidemia is defined as abnormal blood lipid levels and is a major risk factor for coronary heart disease, ischemic stroke, metabolic syndrome and type 2 diabetes, and there are several subtypes of dyslipidemia with different causes. Knowing your genetics risk of developing abnormal blood lipid levels and most effective intervention.
Genetic Testing Provides:
Otogenetics worked with GBInsight to develop this Dyslipidemia Gene Panel, and we want you to have the information you need to understand genes involved with Dyslipidemia once the test is completed. This panel examines genes causing both single and multi-gene risk factors, including rare causes of Dyslipidemia, giving you the comprehensive results needed to understand the risk of developing abnormal blood lipid levels and the best methods for intervention.
Our Next Generation Sequencing (NGS) techniques eliminate ambiguities at every locus compared to other genetic testing methods, giving more accurate results.
The Dyslipidemia Gene Testing is currently offered for research use. Researchers and clinicians can order the tests for clinical investigation purposes. This test will help clinicians identify the potential genetic etiology of Dyslipidemia and help them design more targeted and effective interventions.